Vectura: Pfizer UK to Commercialize Ultibro Breezhaler, Seebri Breezhaler
September 04 2014 - 2:52AM
Dow Jones News
LONDON--Vectura Group PLC (VEC.LN), a developer of therapies for
the treatment of airways-related diseases, on Thursday announced
that its alliance partner Novartis, has confirmed that Pfizer
Limited has signed an exclusive agreement to commercialize Ultibro
Breezhaler and Seebri Breezhaler in the United Kingdom.
Shares closed Wednesday at 135.25 pence.
-Write to Jana Simmons at jana.simmons@wsj.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
Pfizer (NYSE:PFE)
Historical Stock Chart
From Mar 2024 to Apr 2024
Pfizer (NYSE:PFE)
Historical Stock Chart
From Apr 2023 to Apr 2024